A citation-based method for searching scientific literature


List of co-cited articles
145 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
13

Diabetic Neuropathy: A Position Statement by the American Diabetes Association.
Rodica Pop-Busui, Andrew J M Boulton, Eva L Feldman, Vera Bril, Roy Freeman, Rayaz A Malik, Jay M Sosenko, Dan Ziegler. Diabetes Care 2017
632
10

Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
560
10


Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
8

Changes in diabetes-related complications in the United States, 1990-2010.
Edward W Gregg, Yanfeng Li, Jing Wang, Nilka Rios Burrows, Mohammed K Ali, Deborah Rolka, Desmond E Williams, Linda Geiss. N Engl J Med 2014
925
8

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
8

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
8


Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
8



Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
6

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
Aidin Rawshani, Araz Rawshani, Stefan Franzén, Björn Eliasson, Ann-Marie Svensson, Mervete Miftaraj, Darren K McGuire, Naveed Sattar, Annika Rosengren, Soffia Gudbjörnsdottir. N Engl J Med 2017
482
6

Diabetic retinopathy.
Tien Y Wong, Chui Ming Gemmy Cheung, Michael Larsen, Sanjay Sharma, Rafael Simó. Nat Rev Dis Primers 2016
292
6

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
6


Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
George L Bakris, Rajiv Agarwal, Juliana C Chan, Mark E Cooper, Ron T Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E Schmieder, Christina Nowack,[...]. JAMA 2015
291
6

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph,[...]. N Engl J Med 2020
188
6

Liraglutide and Renal Outcomes in Type 2 Diabetes.
Johannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, Steven P Marso, Neil R Poulter, Søren Rasmussen, Karen Tornøe, Bernard Zinman, John B Buse. N Engl J Med 2017
486
6

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
6

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
6


Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.
Maryam Afkarian, Leila R Zelnick, Yoshio N Hall, Patrick J Heagerty, Katherine Tuttle, Noel S Weiss, Ian H de Boer. JAMA 2016
344
6


Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
6

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Kunihiro Matsushita, Marije van der Velde, Brad C Astor, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh, Ron T Gansevoort. Lancet 2010
6

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.
Toshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, Sophia Zoungas, Avinesh Pillai, Meg Jardine, Anushka Patel, Alan Cass, Bruce Neal, Neil Poulter,[...]. J Am Soc Nephrol 2009
595
6

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
6

Classification of diabetic foot wounds.
L A Lavery, D G Armstrong, L B Harkless. J Foot Ankle Surg 1996
213
4

Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update).
Robert J Hinchliffe, Rachael O Forsythe, Jan Apelqvist, Edward J Boyko, Robert Fitridge, Joon Pio Hong, Konstantinos Katsanos, Joseph L Mills, Sigrid Nikol, Jim Reekers,[...]. Diabetes Metab Res Rev 2020
65
4

Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update).
Nicolaas C Schaper, Jaap J van Netten, Jan Apelqvist, Sicco A Bus, Robert J Hinchliffe, Benjamin A Lipsky. Diabetes Metab Res Rev 2020
93
4

Diabetic Foot Ulcers and Their Recurrence.
David G Armstrong, Andrew J M Boulton, Sicco A Bus. N Engl J Med 2017
784
4

The clinical consequences of heterogeneity within and between different diabetes types.
Maria J Redondo, William A Hagopian, Richard Oram, Andrea K Steck, Kendra Vehik, Michael Weedon, Ashok Balasubramanyam, Dana Dabelea. Diabetologia 2020
19
10

Incidence of type 1 diabetes in China, 2010-13: population based study.
Jianping Weng, Zhiguang Zhou, Lixin Guo, Dalong Zhu, Linong Ji, Xiaoping Luo, Yiming Mu, Weiping Jia. BMJ 2018
107
4

Glycemic control and excess mortality in type 1 diabetes.
Marcus Lind, Ann-Marie Svensson, Mikhail Kosiborod, Soffia Gudbjörnsdottir, Aldina Pivodic, Hans Wedel, Sofia Dahlqvist, Mark Clements, Annika Rosengren. N Engl J Med 2014
442
4

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
Trevor J Orchard, David M Nathan, Bernard Zinman, Patricia Cleary, David Brillon, Jye-Yu C Backlund, John M Lachin. JAMA 2015
262
4

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.
Julio Rosenstock, Harpreet S Bajaj, Andrej Janež, Robert Silver, Kamilla Begtrup, Melissa V Hansen, Ting Jia, Ronald Goldenberg. N Engl J Med 2020
45
4

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
Kevan C Herold, Brian N Bundy, S Alice Long, Jeffrey A Bluestone, Linda A DiMeglio, Matthew J Dufort, Stephen E Gitelman, Peter A Gottlieb, Jeffrey P Krischer, Peter S Linsley,[...]. N Engl J Med 2019
215
4

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Sophia Zoungas, John Chalmers, Bruce Neal, Laurent Billot, Qiang Li, Yoichiro Hirakawa, Hisatomi Arima, Helen Monaghan, Rohina Joshi, Stephen Colagiuri,[...]. N Engl J Med 2014
352
4

Chronic Kidney Disease Diagnosis and Management: A Review.
Teresa K Chen, Daphne H Knicely, Morgan E Grams. JAMA 2019
155
4

Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
Yanyan Bai, Jian-xing Ma, Junjing Guo, Juanjuan Wang, Meili Zhu, Ying Chen, Yun-Zheng Le. J Pathol 2009
158
4


Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
Rafael Simó, Cristina Hernández. Trends Endocrinol Metab 2014
250
4

Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11).
Merlin C Thomas, Richard J Macisaac, George Jerums, Andrew Weekes, John Moran, Jonathan E Shaw, Robert C Atkins. Diabetes Care 2009
126
4

Pathologic classification of diabetic nephropathy.
Thijs W Cohen Tervaert, Antien L Mooyaart, Kerstin Amann, Arthur H Cohen, H Terence Cook, Cinthia B Drachenberg, Franco Ferrario, Agnes B Fogo, Mark Haas, Emile de Heer,[...]. J Am Soc Nephrol 2010
683
4

Kidney disease and increased mortality risk in type 2 diabetes.
Maryam Afkarian, Michael C Sachs, Bryan Kestenbaum, Irl B Hirsch, Katherine R Tuttle, Jonathan Himmelfarb, Ian H de Boer. J Am Soc Nephrol 2013
499
4



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.